Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
about
Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomasNovel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumorsSDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaSuccinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.Succinate dehydrogenase-deficient gastrointestinal stromal tumors.Gastrointestinal stromal tumor - an evolving concept.Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.Succinate dehydrogenase expression in breast cancer.Hereditary Pheochromocytoma.Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess.Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.Points to consider in the clinical use of NGS panels for mitochondrial disease: an analysis of gene inclusion and consent forms.Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.
P2860
Q26752945-A6D49768-4213-433B-832D-C469054B70DBQ27001114-EF229564-5E27-4B27-839E-9CB3CABBC070Q33853615-B989DEBE-FB88-4FD9-B6CD-B51526D5D283Q33954761-40BA8E3F-3E7F-4619-AB51-A580284EA548Q34668378-C76CA099-3FE5-4F2B-BCB9-4EB6E5AB7F32Q34928165-F1364DE5-31DE-4DFE-A699-A474A373DA36Q35589566-63851AD5-2C7A-41A4-9395-FF244DF14A92Q37009756-ABD1CDC5-D763-4E96-ABF8-EBE9B0D6A91DQ38218035-C9373DCF-DB16-4F90-85C2-7E3F34208961Q40243503-188384D4-A8F5-4567-89EF-E107055C5550Q45833523-847D54B4-574B-4995-8D12-0008A0364E8DQ46077309-13A80F06-3CE6-4D23-9843-C89B9F3163A6Q47611089-B962CA01-9FF9-4AC0-9EE4-8C84E1886FB7Q48289707-A5B90315-FC33-4351-BBFF-98088CD4027AQ52757920-62229D81-30D1-4092-AABD-508F1F7F5CD9Q54976922-A61FBB8E-936B-4FF1-BB7B-FD9A3B1A3751
P2860
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@ast
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@en
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@nl
type
label
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@ast
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@en
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@nl
prefLabel
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@ast
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@en
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@nl
P1476
Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
@en
P2093
Jason L Hornick
Justine A Barletta
P304
P356
10.1097/PAP.0B013E31825C6BC6
P577
2012-07-01T00:00:00Z